Differential retinal angiogenic response to sustained intravitreal release of VEGF and bFGF in different pigmented rabbit breeds
暂无分享,去创建一个
K. Osann | B. Kuppermann | C G Wong | K Osann | M. Erb | C. Sioulis | C. G. Wong | M H Erb | C E Sioulis | B D Kuppermann | C. G. Wong | M. H. Erb
[1] M. Musarella. Molecular genetics of macular degeneration , 2001, Documenta Ophthalmologica.
[2] U. Schraermeyer,et al. Retinal pigment epithelial cells: autocrine and paracrine stimulation of extracellular matrix contraction , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.
[3] S. Ross,et al. Genetic risk factors in diabetic retinopathy , 1993, Diabetologia.
[4] J. Cunha-Vaz,et al. Novel imaging techniques for diabetic macular edema , 2004, Documenta Ophthalmologica.
[5] M. Berns,et al. Bioengineering Retinal Blood Vessels with Pro-Angiogenic Polymeric Scaffolds , 2002 .
[6] R. Klein,et al. HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. , 2002, Ophthalmology.
[7] Franklin Peale,et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium , 2001, Nature.
[8] P. Campochiaro,et al. Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization , 2001, Journal of cellular physiology.
[9] A Erginay,et al. Reproducibility of retinal mapping using optical coherence tomography. , 2001, Archives of ophthalmology.
[10] G. Desoye,et al. Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity , 2001, Cell proliferation.
[11] M. Votruba,et al. Neovascular age-related macular degeneration: Present and future treatment options , 2001, Eye.
[12] M. Boulton,et al. The role of the retinal pigment epithelium: Topographical variation and ageing changes , 2001, Eye.
[13] Michael W. Berns,et al. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit , 2001, Current eye research.
[14] S. Chakrabarti,et al. Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy , 2000, Diabetes/metabolism research and reviews.
[15] L. Aiello,et al. Role of vascular endothelial growth factor in diabetic vascular complications. , 2000, Kidney international. Supplement.
[16] R. D'Amato,et al. Genetic heterogeneity of angiogenesis in mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] P. Campochiaro,et al. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. , 1999, Molecular vision.
[18] W. Benedict,et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.
[19] S. Bressler,et al. Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye. , 1998, Current opinion in ophthalmology.
[20] Zhongping Chen,et al. Optical Doppler Tomography: Imaging in vivo Blood Flow Dynamics Following Pharmacological Intervention and Photodynamic Therapy , 1998, Photochemistry and photobiology.
[21] P. Campochiaro,et al. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. , 1998, Experimental eye research.
[22] Weiheng Chen,et al. Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels. , 1997, Investigative ophthalmology & visual science.
[23] Einar Stefánsson,et al. Retinal vessel dilatation and elongation precedes diabetic macular oedema , 1997, The British journal of ophthalmology.
[24] B. Saville,et al. Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume. , 1997, Current eye research.
[25] Joan W. Miller,et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.
[26] Å. Lernmark,et al. HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM , 1996, Diabetologia.
[27] T. Huang,et al. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom. , 1996, Investigative ophthalmology & visual science.
[28] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[29] P. D'Amore,et al. Mechanisms of retinal and choroidal neovascularization. , 1994, Investigative ophthalmology & visual science.
[30] S. Wahab. Traction retinal detachment. XLIX Edward Jackson Memorial Lecture. , 1994, American journal of ophthalmology.
[31] Z. Gregor,et al. Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. , 1994, The British journal of ophthalmology.
[32] J. Folkman,et al. Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .
[33] D Verma,et al. Pathogenesis of diabetic retinopathy--the missing link? , 1993, Medical hypotheses.
[34] L. Mandarino. Current Hypotheses for the Biochemical Basis of Diabetic Retinopathy , 1992, Diabetes Care.
[35] K. Skorecki,et al. Promoter region of the murine fibroblast growth factor receptor 2 (bek/KGFR) gene. , 1992, Oncogene.
[36] B. Glaser,et al. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. , 1987, Ophthalmology.
[37] W. Tasman,et al. Cryotherapy for active retinopathy of prematurity. , 1986, Ophthalmology.
[38] Z. Gregor,et al. Senile macular changes in the black African. , 1978, The British journal of ophthalmology.
[39] R Hiller,et al. Blindness caused by diabetic retinopathy. , 1974, American journal of ophthalmology.